GUANFACINE

guanfacine 3 mg modified release tablet, 28

GUANFACINE (11440D)

guanfacine 3 mg modified release tablet, 28
11440D
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  9034

Indication: Attention deficit hyperactivity disorder
Treatment phase: Initial treatment

Restriction  9031

Indication: Attention deficit hyperactivity disorder
Treatment phase: Continuing treatment

Restriction  8544

Indication: Attention deficit hyperactivity disorder
Treatment phase: Initial treatment

Restriction  8585

Indication: Attention deficit hyperactivity disorder
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 28 # of repeats: 5 DPMQ: $65.63 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Intuniv